PROPRIETARY INFORMATION AND UNFAIR COMPETITION. 4.1. You acknowledge that in the course of your employment with the Company, you will be entrusted with access to extensive confidential information of the Company concerning its products and service, methods of manufacture, research and development, know-how, patents, copyrights, trademarks, and other proprietary data, as well as the identity, needs, and preferences of its customers and prospects, all of which the Company considers its legally protected trade secrets and intellectual property. You further acknowledge the highly competitive nature of the business of the Company, and the fact that unauthorized disclosure or use of such trade secrets and intellectual property would be inevitable if you were to compete with the Company or solicit competing business from its prospects and customers. You therefore agree that in the event of a termination following a Change of Control as described in this Agreement, the following provisions shall apply: 4.2. Commencing on the Date of Termination, and ending two years thereafter (the "Non-Compete Period"), you will not provide goods or services to or become an employee, owner (except for passive investments of not more than three percent of the outstanding shares of, or any other equity interest in, any company or entity listed or traded on a national securities exchange or in an over-the-counter securities market), officer, agent, consultant, advisor or director of any firm or person in any geographic area which competes in the "Business". For purposes of this Agreement, the term "Business" shall mean the research, design, development, manufacture, sale or distribution of ultrasound contrast agents.
Appears in 4 contracts
Samples: Change in Control Agreement (Sonus Pharmaceuticals Inc), Change in Control Agreement (Sonus Pharmaceuticals Inc), Change in Control Agreement (Sonus Pharmaceuticals Inc)